{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CHSCN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CHSCN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CHSCN\",,,,,undefined,":{"symbol":"CHSCN","market":"US","secType":"STK","nameCN":"CHS Inc","latestPrice":25.28,"timestamp":1747146747981,"preClose":25.29,"halted":0,"volume":488,"delay":0,"floatShares":12272000,"shares":12272000,"eps":0,"marketStatus":"Trading","change":-0.01,"latestTime":"05-13 10:36:08 EDT","open":25.28,"high":25.28,"low":25.28,"amount":12321.127944,"amplitude":0,"askPrice":25.32,"askSize":10,"bidPrice":25.15,"bidSize":1,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1747166400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":25.29,"postHourTrading":{"tag":"盘后","latestPrice":25.29,"preClose":25.29,"latestTime":"16:05 EDT","volume":2,"amount":50.58,"timestamp":1747080311757},"volumeRatio":0.318846},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CHSCN\",,,,,undefined,":{"symbol":"CHSCN","floatShares":12272000,"roa":"0.33%","roe":"5.39%","lyrEps":0,"volumeRatio":0.318846,"shares":12272000,"dividePrice":1.775,"high":25.28,"amplitude":0,"preClose":25.29,"low":25.28,"week52Low":24.48,"pbRate":"0.04","psRate":"0.01","week52High":26.71,"institutionHeld":0,"latestPrice":25.28,"committee":-0.818182,"eps":0,"divideRate":0.070214,"volume":488,"delay":0,"ttmEps":0,"open":25.28,"prevYearClose":25.26,"prevWeekClose":25.13,"prevMonthClose":25.25,"prevQuarterClose":25,"fiveDayClose":25.26,"twentyDayClose":24.7896,"sixtyDayClose":25.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CHSCN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529714672","title":"Community Health Systems Subsidiary Kicks Off Cash Tender Offer for 2028 Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2529714672","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529714672?lang=en_us&edition=fundamental","pubTime":"2025-04-24 17:37","pubTimestamp":1745487437,"startTime":"0","endTime":"0","summary":"Community Health Systems  said late Wednesday its wholly owned subsidiary, CHS/Community Health Systems, started a cash tender offer for 6.875% senior unsecured notes due 2028.The company said the aggregate principal amount of the notes outstanding is almost $625.9 million.The offer will expire May 21, unless the company extends or terminates it early.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CHSCM","CHSCO","CYH","BK4189","CHSCN","CHSCL","BK4185"],"gpt_icon":0},{"id":"2505051920","title":"GEECHS Inc. Acquires Alive Inc. to Boost IT Market Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2505051920","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505051920?lang=en_us&edition=fundamental","pubTime":"2025-01-23 14:53","pubTimestamp":1737615214,"startTime":"0","endTime":"0","summary":"An update from geechs inc. ( ($JP:7060) ) is now available. GEECHS Inc. has announced its decision to acquire 100% of Alive Inc.’s shares, making i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/geechs-inc-acquires-alive-inc-to-boost-it-market-presence?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/geechs-inc-acquires-alive-inc-to-boost-it-market-presence?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4189","CHSCM","CHSCN","CHSCL"],"gpt_icon":0},{"id":"2492175116","title":"AbbVie's atogepant and onabotulinumtoxinA receive strong recommendations in the newly updated Canadian Headache Society (CHS) Migraine Prevention Guideline","url":"https://stock-news.laohu8.com/highlight/detail?id=2492175116","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492175116?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:00","pubTimestamp":1734613200,"startTime":"0","endTime":"0","summary":"The 2024 Canadian Headache Society  Migraine Prevention Guideline, which replaces the previous version published in 2012, granted strong recommendations for atogepant in episodic and chronic migraine, and for onabotulinumtoxinA in chronic migraine.1. The new CHS Migraine Prevention Guideline is based on a comprehensive systematic review and meta-analysis and addresses both episodic and chronic migraine.1. A strong recommendation was issued when an intervention was deemed suitable for the majority of patients, with benefits outweighing potential risks.1. The previous guideline, published in 2012, has been updated due to the approval of several new treatments in recent years. Moreover, the previous version did not address chronic migraine. The new CHS Migraine Prevention Guideline is based on a comprehensive systematic review and meta-analysis and addresses both episodic and chronic migraine. A strong recommendation was issued when an intervention was deemed suitable for the majority of ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dUh8WyQQFmRcaCAMOd439Q--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/cnwgroup.com/7ce5a1b5322122bc0323116739cb329f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dUh8WyQQFmRcaCAMOd439Q--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/cnwgroup.com/7ce5a1b5322122bc0323116739cb329f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abbvies-atogepant-onabotulinumtoxina-receive-strong-130000835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0965509283.SGD","LU0128525929.USD","LU1093756168.USD","SG9999015952.SGD","LU0943347566.SGD","BK4533","LU2347655156.SGD","LU2112291526.USD","LU2237443465.HKD","LU0310800379.SGD","LU1093756325.SGD","LU1585245621.USD","LU0310799852.SGD","CHSCO","LU1732799900.SGD","IE00BFTCPJ56.SGD","LU1989772923.USD","BK4585","LU0738911758.USD","LU0912757837.SGD","LU0211328371.USD","SG9999015945.SGD","LU1003077747.HKD","LU0965509101.SGD","LU1934455194.USD","LU0661504455.SGD","ABBV","IE00B2B36J28.USD","LU1989772840.SGD","IHS","LU0417517546.SGD","LU1551013425.SGD","SG9999011175.SGD","LU0234572021.USD","SG9999015986.USD","LU0114720955.EUR","LU1839511570.USD","LU1934455277.USD","CHSCM","LU2237443622.USD","LU1989771016.USD","LU0795875086.SGD","LU0029864427.USD","LU1551013342.USD","CHS","CHSCN","CHSCL","LU0545039389.USD","SG9999001440.SGD"],"gpt_icon":0},{"id":"2492185616","title":"Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2492185616","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492185616?lang=en_us&edition=fundamental","pubTime":"2024-12-18 21:30","pubTimestamp":1734528600,"startTime":"0","endTime":"0","summary":"- Randomized Phase 2 study initiated evaluating the combination of casdozokitug, toripalimab and bevacizumab in patients with liver cancer - REDWOOD CITY, Calif., Dec.  18, 2024  (GLOBE NEWSWIRE) -- C","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/18/2999051/33333/en/Coherus-to-Present-Final-Phase-2-Casdozokitug-Combination-Data-in-Patients-with-Metastatic-Hepatocellular-Carcinoma-at-ASCO-GI-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4107","BK4006","BK4189","BK4585","L","BK4121","CHSCN","CHSCO","CHSCM","CHSCL","BK4535","LU0053666078.USD","SEER","CHRS","HCC"],"gpt_icon":0},{"id":"2486917858","title":"Community Health Ends Hospital Sale Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2486917858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486917858?lang=en_us&edition=fundamental","pubTime":"2024-11-27 05:59","pubTimestamp":1732658386,"startTime":"0","endTime":"0","summary":"An update from Community Health ( ($CYH) ) is now available. Community Health Systems, Inc. (CHS) and WoodBridge Healthcare, Inc. have mutually agr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/community-health-ends-hospital-sale-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/community-health-ends-hospital-sale-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHSCL","CHS","CHSCM","BK4189","CHSCN","BK4185","CHSCO","BK4094","CYH"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CHSCN\",params:#limit:5,,,undefined,":[{"date":"2025-06-13","symbol":"CHSCN","amount":0.44375,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-13","defaultRemindTime":1749821400000,"name":"CHS Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-13","currency":"USD","dateTimestamp":1749787200000,"payDate":"2025-06-30"},{"market":"US","date":"2025-04-02","symbol":"CHSCN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1743566400000,"reportTimeType":"","actualEps":null},{"date":"2025-03-17","symbol":"CHSCN","amount":0.44375,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-17","defaultRemindTime":1742218200000,"name":"CHS Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-17","currency":"USD","dateTimestamp":1742184000000,"payDate":"2025-03-31"},{"date":"2025-01-08","symbol":"CHSCN","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1736326800000,"name":null,"time":"","dateTimestamp":1736312400000,"actualEps":null},{"date":"2024-12-17","symbol":"CHSCN","amount":0.44375,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"CHS Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CHSCN\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-12","recordDate":"2015-06-16","paymentDate":"2015-06-30","value":0.44375,"currency":"USD"},{"executeDate":"2015-09-14","recordDate":"2015-09-16","paymentDate":"2015-09-30","value":0.44375,"currency":"USD"},{"executeDate":"2015-12-14","recordDate":"2015-12-16","paymentDate":"2015-12-31","value":0.44375,"currency":"USD"},{"executeDate":"2016-03-15","recordDate":"2016-03-17","paymentDate":"2016-03-31","value":0.44375,"currency":"USD"},{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-30","value":0.44375,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CHSCN\",market:\"US\",delay:false,,,undefined,":{}}}